Benzinga | Aug 20, 2020 04:08PM EDT

Kodiak Sciences And Kodiak Sciences GmbH On August 14 Entered Into A Bioconjugation Addendum With Lonza For Manufacturing Of Clinical And Commercial Supply Of Drug Substance For KSI-301